The European Commission (EC) has granted a label extension in the European Union (EU) for Eylea 8mg (aflibercept 8mg, 114.3mg/ml...
Read moreDetailsResearchers in the US are developing an experimental drug to slow or halt damage to the eye from diabetic retinopathy....
Read moreDetailsAt the completion of this article, the reader should… • Have reviewed screening guidelines to assess diabetic retinopathy based on...
Read moreDetailsResearchers in the US have found that low blood sugar, or hypoglycemia, may promote a breakdown of the blood-retinal barrier,...
Read moreDetailsAt the completion of this article, the reader should be able to improve their management of dry eye disease in...
Read moreDetailsNew research from the University of Sydney reveals the number of Australians living with diabetes may be up to 35%...
Read moreDetailsAmid concerns that automated insulin delivery (AID) systems can worsen diabetic retinopathy, an Australasian study has demonstrated most people with...
Read moreDetailsResearchers are urging caution in the use of popular weight-loss drugs Ozempic and Wegovy after a link was established between...
Read moreDetailsTwo Australian ophthalmologists speak to Insight about why they are excited about the double-release of new ARTEVO microscopes from ZEISS...
Read moreDetailsOphthalmologist and 2020 Australian of the Year DR JAMES MUECKE has been a prominent voice in a recent government inquiry...
Read moreDetailsInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited